This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1097/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q82254954
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в серпні 2008 wetenschappelijk artikel artículu científicu espublizáu n'agostu de 2008 scientific article published on 01 August 2008
p:P577
wds:Q82254954-4FA95F5F-BDB8-41CE-9420-77FFD3577C9D
wdt:P577
2008-08-01T00:00:00Z
p:P2093
wds:Q82254954-0957748F-E8E9-4B68-B61E-59817463984D wds:Q82254954-16EBEB95-B8EC-4057-A661-B688760F17B6 wds:Q82254954-070421E0-22CB-475D-A8BB-6DF66C3AFCF4 wds:Q82254954-193308AC-1F88-4C37-9914-D14AC5C80691 wds:Q82254954-A0C5CBB6-1A9F-4CCC-80EA-6523B7068723 wds:Q82254954-7336FD4A-875E-477C-AD7B-53F568BD332A wds:Q82254954-B18BACAB-1F01-4994-AD86-A38CAAE4FE1C wds:Q82254954-AF1F6E49-1FC1-4416-B01B-AA40751BF251 wds:Q82254954-B0DBAB0D-B581-4392-B0EC-F1DF0D255726 wds:Q82254954-CAC422F7-4F89-4CFC-B2E8-D1DB4286346B wds:Q82254954-D6E9E86C-23A1-47B7-A43A-41AD6C0DD295 wds:Q82254954-C714BEE1-52EF-4003-8665-7EA4CE523EAD wds:Q82254954-E54F57C6-2500-4109-A4A2-B3F78D28980C
wdt:P2093
Jean-Philippe Jacquin Cyrille Colin Isabelle Mechin-Cretinon Cécile Fournel Bénédicte Poncet Jean-Dominique Tigaud Isabelle Jaisson-Hot Christell Ganne Hubert Orfeuvre Bruno Salles François Marechal Pierre-Yves Peaud Véronique Trillet-Lenoir
rdfs:label
Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis
skos:prefLabel
Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis
schema:name
Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis
p:P50
wds:Q82254954-EB54BAC8-C901-491E-8E83-3A3F3419ABD1
wdt:P50
wd:Q89504757
p:P1476
wds:Q82254954-43AE04E7-028F-4A6B-8525-23CD9CB92C73
wdt:P1476
Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis
p:P304
wds:Q82254954-3923DE8F-C81E-432E-BE42-0D7078618487
wdt:P304
363-368
p:P31
wds:Q82254954-468092C9-1F36-4103-914B-EFF3B5FC4069
wdt:P31
wd:Q13442814
p:P921
wds:Q82254954-6CA38D71-CBDE-4A0C-AA5E-A9CFB777B6AD wds:Q82254954-92704F0F-F6B0-4BDA-A5B6-DA32DC92FECA wds:Q82254954-3ECEF628-E44D-43A1-8752-93DA0926CCD5
wdt:P921
wd:Q412616 wd:Q422248 wd:Q12859063
p:P698
wds:Q82254954-870095BE-7EE1-447A-881B-8CDC251B71A2
wdtn:P698
n12:18845995
wdt:P698
18845995
p:P1433
wds:Q82254954-5E2A1163-0AD5-4397-9593-2885212D6F9D
wdt:P1433
wd:Q2886177
p:P433
wds:Q82254954-BA99351A-401F-4CAB-BE77-78B8970079A0
p:P478
wds:Q82254954-C9E77368-9BAA-4366-A7A3-CD0330C902F8
wdt:P433
4
wdt:P478
31
p:P356
wds:Q82254954-00B365D7-A4F7-4E3C-BECD-E2A4633A1797
wdtn:P356
n10:COC.0B013E3181637356
wdt:P356
10.1097/COC.0B013E3181637356